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Brief Definitive Report 
HUMAN CD3 + T LYMPHOCYTES THAT EXPRESS NE ITHER 
CD4 NOR CD8 ANTIGENS 
BY LEWIS L. LANIER, JOYCE J. RUITENBERG, AND JOSEPH H. PHILLIPS 
From the Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043 
Differential expression of  the CD4 and CD8 antigens on T lymphocytes has 
been used as a basis to construct models of thymic differentiation, and to identify 
functionally distinct subsets of  T cells (1, 2). In the thymus, most cells coexpress 
both CD4 and CD8, while minor subpopulations express the phenotypes 
CD4-,8-;  CD4+,8-; and CD4-,8 + (1, 2). It has been proposed that during thymic 
ontogeny CD4-,8-  precursor cells differentiate into CD4÷,8 + thymocytes. Upon 
maturation, CD4+,8 + thymocytes acquire the CD3/T i  complex and presumably 
lose either CD4 or CD8, then CD3÷,4+,8 - and CD3+,4-,8 + T lymphocytes 
migrate into peripheral tissues (1, 2). Mature CD3+,4+,8 - T cells augment Ig 
secretion by B lymphocytes and facilitate the generation of cytotoxic T cells, 
whereas CD3+,4-,8 + T cells predominately mediate cytotoxicity and immune 
suppression (3, 4). In general, antigenic recognition by CD4 + T cells is restricted 
by class II MHC gene products, whereas antigenic recognition by CD8 ÷ cells is 
restricted by class I MHC antigens (5, 6). It has been generally accepted that all 
peripheral T cells express either CD4 or CD8, with a minor population expressing 
both antigens. However, we have recently observed that a small subset of  human 
peripheral blood CD3 + T lymphocytes express neither CD4 nor CD8. Herein, 
we describe the characteristics of this unique subset of T cells. 
Mater ia ls  and  Methods  
Isolation of Peripheral Blood CD3+,4-,8 - T Lymphocytes. Mononuclear cells from normal 
peripheral blood (Stanford Blood Center, Palo Alto, CA) were isolated using Fi- 
coll/Hypaque. Monocytes were depleted by plastic adherence. Nonadherent cells were 
stained with a mixture of FITC-conjugated anti-Leu-2 (CD8), FITC-conjugated anti-Leu- 
3 (CD4), and phycoerythrin (PE)-conjugated anti-Leu-4 (CD3) (7). After extensive washing 
in ice cold PBS, the cells were resuspended in PBS containing 1% FCS. Lymphocytes 
expressing CD3, but lacking both CD4 and CD8, would therefore show specific red (PE) 
fluorescence, but not green (FITC) fluorescence, CD3+,4-,8 - cells were isolated to >95% 
purity using a FACS 440 (Becton Dickinson lmmunocytometry Systems, Mountain View, 
CA) (7). Fluorochrome-conjugated, isotype-matched control antibodies were used to 
establish the specificity of antibody binding (7). 
Antibodies. Anti-Leu-1, -Leu-2, -Leu-3, -Leu-4, -Leu-5, -Leu-6, -Leu-11, and -Leu-12 
react with the CD5, CD8, CD4, CD3, CD2, CD1, CD16, and CD19 differentiation 
antigens, respectively. Anti-Leu-19 reacts with the Leu-19 (NKH-1) antigen, which is 
present on NK cells and a subset of T lymphocytes (8). 
lmmunofluorescence and Flow Cytometry. Methods of immunofluorescence, flow cytom- 
etry, and data analysis have been presented elsewhere (7, 9). 
Cytotoxicity Assays. 5~Cr-labeled tumor cells were used as targets in a 4-h radioisotope 
release assay (7). 
Cell Culture. Cells were cultured in RPMI 1640 supplemented with 10% FCS (KC 
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FIGURE 1. CD3 ÷ T cells expressing neither CD4 nor CD8. (A) Lymphocytes were stained 
with FITC-IgG and PE-IgG control antibodies (left) or PE anti-Leu-4 (CD3) and a mixture of 
F1TC anti-Leu-3 (CD4) and FITC anti-Leu-2 (CDS) (right). Based on the control sample, the 
contour plot was divided into quadrants representing unstained cells (lower left), cells with only 
red fluorescence (upper left), cells with red and green fuorescence (upper ight), and cells with 
only green fluorescence (lower right). Lymphocytes expressing CD3, but lacking both CD4 and 
CD8 would therefore be present in the upper left quadrant (i.e., red is positive, green is 
negative). In this individual, 79.8% of lymphocytes expressed the CD3 antigen, and 8.5% 
were CD3+,4-,8 -. In the Ig isotype-matched control sample, <0.01% of lymphocytes were 
present in the upper left quadrant and >98% were unstained (lower left quadrant), a, anti. (B) 
In vitro cultured CD3÷,4-,8 - lymphocytes were stained as described in (A). 90% of the 
lymphocytes were CD3+4-,8 -. Note that 10% of the lymphocytes were stained both red (CD3 +) 
and dim green (upper left). Immunofluorescent staining with only FITC anti-Leu-2 and PE 
anti-Leu-4 gave an identical profile, indicating that these cells were CD3+,CD8 a~=+ (not shown). 
No CD4 + lymphocytes were detected in these cultures, a, anti. 
Biologicals, Lexena, KS), 1 mM glutamine, 100 #g/ml gentamicin, and 1000 U/ml rlL-2 
(Cetus Corp., Emeryville, CA). 
Results and Discussion 
Peripheral blood lymphocytes from normal donors were stained with PE anti- 
Leu-4 (CD3) and a mxiture of FITC anti-Leu-2 (CD8) and FITC anti-Leu-3 
(CD4) and were analyzed by flow cytometry. A small subset of cells expressed 
CD3 antigen (a component of the T cell antigen receptor), but lacked both CD4 
and CD8 (Fig. 1). Based on analysis of >20 normal blood donors, ~3% of blood 
lymphocytes comprised CD3+,4-,8 - T lymphocytes (range, <0.5-23%) (~78% 
of lymphocytes were CD3+). The specificity of the staining was confirmed by 
showing that an identical percentage of lymphocytes was observed using a 
reciprocal set of reagents (i.e., FITC anti-Leu-4 and a mixture of PE anti-Leu-2 
and PE anti-Leu-3), and by direct three-color immunofluorescence analysis using 
FITC anti-Leu-2, PE anti-Leu-3, and APC anti-Leu-4 (not shown). 1By three- 
color immunofluorescence, 2 we also determined that >90% of the CD3+,4-,8 - 
Identical results have also been obtained using the T3, T4 and T8 mAbs (Coulter Immunology, 
Hialeah, FL). 
This was determined by three-color immunofluorescence by staining lymphocytes with APC 
streptavidin/biotin a ti-Leu-4 (CD3), a mixture of PE anti-Leu-2 and PE anti-Leu-3, and a third 
FITC-conjugated antibody (e.g., FITC anti-Leu-1 [CD5], FITC anti-Leu-5 [CD2 l, etc.). By gating 
on CD3+,4-,8 - (APC+,PE--stained) lymphocytes, it was possible to determine the proportion of 
CD3+,4-,8 - cells that expressed the antigen detected by the F1TC-conjugated antibody. 
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cells coexpressed the CD2 and CD5 pan T cell antigens, but did not express 
antigens associated with B cells (CD 19), N K cells (CD 16), thymocytes (CD 1), or 
monocytes (Leu-M3). 
CD3÷,4-,8 - iymphocytes were isolated to >90% purity using a FACS. 105 cells 
were placed into culture in medium containing rIL-2. After 2 wk, -5  × 106 cells 
were recovered and reanalyzed for expression of CD4 and CD8. >99% of the 
rIL-2-cultured lymphocytes expressed CD3, and 90% were CD3+,4-,8 - (Fig. 
1B). We failed to detect any cells (<0.5%) that expressed either CD4 or CD16. 
These results clearly show that CD3+,4-,8 - T lymphocytes can proliferate in 
response to rIL-2 without deliberate antigenic stimulation and that the 
CD3+,4-,8 - phenotype is stably maintained. It should be noted however that 
10% of the rIL-2-cuitured CD3 + T cells did express CD8 antigen, but in 
approximately one-tenth of the amount present on typical blood CD3+,8 + T 
lymphocytes. Lymphocytes expressing "dim" CD8 have been described; however, 
in these prior reports most CD8 dim+ cells lacked CD3 and were CD3-, CD16 + 
NK cells (7). Whether CD3+,CD4-,CD8 dim+ lymphocytes were generated from 
the CD3÷,4-,8 - population or were a contaminant in the isolation procedure is 
unknown. 
Morphological examination revealed that >80% of CD3+,4-,8 - cells cultured 
only in rIL-2 were large lymphoblasts with abundant cytoplasm containing 
predominant azurophilic granules (Fig. 2 A). In contrast, >90 % of freshly isolated 
CD3+,4-,8 - cells were agranular lymphocytes, although a small proportion of 
granular cells was observed in some donors (Fig. 2B). Since both NK cells and 
some CTL possess this characteristic granular morphology, these cells were 
tested for cytotoxic activity. CD3+,4-,8 - T cells cultured only in rIL-2 lysed NK- 
sensitive K562 and NK-insensitive JY targets (Fig. 3A). Since K562 lacks cell 
surface expression of both class I and II MHC antigens, these results show that 
rIL-2-cultured CD3+,4-,8 - T lymphocytes recognize and lyse tumor cell targets 
without MHC restriction. Freshly isolated CD3+,4-,8 - T cells did not lyse K562 
(Fig. 3B). The rIL-2-activated CD3+,4-,8 - cells could be distinguished from 
freshly isolated CD3+,4-,8 - cells based on expression of Leu-19 antigen. >70% 
of rIL-2-stimulated CD3+,4-,8 - cells expressed Leu- 19, whereas generally <10% 
of freshly isolated CD3+,4-,8 - cells expressed Leu-19. Recently, we have shown 
that the Leu-19 antigen is expressed on essentially all peripheral blood CD3- 
NK cells, but is also present on a small subset of freshly isolated peripheral blood 
CD3 + T lymphocytes (most of which express CD8) that mediate non-MHC- 
restricted cytotoxicity (8). 
The cytotoxicity mediated by rIL-2-cultured CD3+,4-,8 - lymphocytes against 
K562 was significantly augmented by the presence of soluble anti-Leu-4 antibody 
in the cytotoxicity assay (Fig. 4). Although anti-CD3 antibodies generally inhibit 
the cytotoxic function of antigen-specific CTL activity against he specific target 
antigen, it has been observed that anti-CD3 antibodies actually induce non- 
specific iyse of inappropriate targets (10). The finding that anti-CD3 induces, 
rather than inhibits, the cytotoxicity of the rIL-2-activated CD3+,4-,8 - cells 
suggests that this population may be polyclonal, containing cytotoxic cells of 
several specificities which are triggered in the presence of anti-CD3. 
These results are compatible with the hypothesis that the peripheral blood 
CD3+,4-,8 - population is polyclonal, and that a Leu-19 + cytotoxic subset within 
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FIGURE 2. Morphology of CD3÷,4-,8 - T lymphocytes. Cells were cytocentrifuged onto glass 
slides and stained with Giemsa. (A) rlL-2-cultured CD3+,4-,8 - lymphocytes; (B) freshly isolated 
peripheral blood CD3+,4-,8 - lymphocytes. Magnification, ×6,000. 
the CD3+,4- ,8  - popu la t ion  can pro l i fe rate  d i rect ly  in response to r lL -2 ,  wi thout  
de l iberate  ant igenic  st imulat ion.  Fur ther  studies on the precursors  o f  the cyto- 
toxic cells within the CD3+,4- ,8  - subset will be necessary to ident i fy  the f requency  
and  phenotype  o f  these cells, and  invest igate thei r  re lat ionship  to the lymphok ine-  
act ivated ki l ler phenomenon.  
The  existence o f  CD3+,4- ,8  - T lymphocytes  hows that a minor  subset o f  
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FIGURE 3. Cytotoxicity mediated by CD4-,8- T lymphocytes (A) An rlL-2-culturefl 
CD3+,4-,8 - cell line shown in Fig. 1 B, was assayed for cytotoxicity against K562 (closed symbols) 
and JY (open symbols). (B) Lymphocytes were stained with PE anti-Leu-1 and a mixture of 
FITC anti-Leu-2, FITC anti-Leu-3, and FITC anti-Leu-12. Lymphocytes that showed exclu- 
sively red immunofiuorescence (i. ., CD5+,4-,8-,12 -) were isolated with a FACS to >95% 
purity. These freshly isolated CD5+,4-,8 - T lymphocytes (O) were assayed for cytotoxicity 
against K562. In these experiments, T cells were identified with an antibody against CD5 
rather than CD3, since antibodies against CD3 have been shown to either induce or inhibit 
cytotoxic function (10). >95% of the CD5+,4-,8-,12 - lymphocytes coexpressed CD3, as 
determined by three-color immunofluorescence analysis. FITC anti-Leu-12 (CD19, pan B cell 
antigen) was used to exclude any CD5 + B lymphocytes from the T lymphocyte population. As 
a positive control, NK cells (A), i.e., the CD5-,4-,8-,19- population, were isolated from the 
same individual's blood and assayed for cytotoxicity. 
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FIGURE 4. Effect ofanti-CD3 on cytotoxicity, rlL-2-cultured CD3÷,4-,8 - cells were assayed 
for cytotoxicity against K562 in the presence (O) or absence (O) of soluble anti-Leu-4 antibody 
(final concentration 2 #g/ml) in the 4 h radioisotope release assay, a, anti; abscissa, E/T ratio. 
functionally competent peripheral T cells apparently does not require either 
CD4 or CD8 expression. Furthermore, these studies raise questions regarding 
the origin of these unique T cells. Recently, De La Hera et al. (11) have reported 
that in vitro culture of CD3+,4-,8 - thymocytes in IL-2 results in the generation 
of non-MHC-restricted cytotoxic ells. It seems likely that these thymocytes are 
the immediate precursor for the CD3+,4-,8 - T lymphocytes that we have 
detected in peripheral blood. 
Summary 
CD3 + T lymphocytes expressing neither CD4 nor CD8 antigens exist in normal 
human peripheral blood in low frequency (~3% of lymphocytes). The 
CD3+,4-,8 - phenotype was stably maintained after in vitro culture in IL-2. 
Culture of CD3+,4-,8 - cells in only rlL-2 generated cytotoxic T cells that lysed 
NK-sensitive and NK-insensitive tumor cell targets without MHC restriction. 
These experiments clearly show that phenotypically and functionally competent 
T cells expressing neither CD4 nor CD8 are present in normal peripheral blood. 
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